Graham CH - Search Results

1

A primer on tumour immunology and prostate cancer immunotherapy.

Ren R, Koti M, Hamilton T, Graham CH, Nayak JG, Singh J, Drachenberg DE, Siemens DR. Ren R, et al. Among authors: graham ch. Can Urol Assoc J. 2016 Jan-Feb;10(1-2):60-5. doi: 10.5489/cuaj.3418. Can Urol Assoc J. 2016. PMID: 26977209 Free PMC article. Review. No abstract available.

2

Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate.

Frederiksen LJ, Siemens DR, Heaton JP, Maxwell LR, Adams MA, Graham CH. Frederiksen LJ, et al. Among authors: graham ch. J Urol. 2003 Sep;170(3):1003-7. doi: 10.1097/01.ju.0000081126.71235.e0. J Urol. 2003. PMID: 12913759

3

Stimulation of human breast carcinoma cell invasiveness and urokinase plasminogen activator activity by glucose deprivation.

Belkacemi L, Lam E, Caldwell JD, Siemens DR, Graham CH. Belkacemi L, et al. Among authors: graham ch. Exp Cell Res. 2006 Jun 10;312(10):1685-92. doi: 10.1016/j.yexcr.2006.02.004. Epub 2006 Mar 27. Exp Cell Res. 2006. PMID: 16564525

4

Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells.

Bell EN, Tse MY, Frederiksen LJ, Gardhouse A, Pang SC, Graham CH, Siemens DR. Bell EN, et al. Among authors: graham ch. J Urol. 2007 Feb;177(2):751-6. doi: 10.1016/j.juro.2006.09.075. J Urol. 2007. PMID: 17222675

5

Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.

Frederiksen LJ, Sullivan R, Maxwell LR, Macdonald-Goodfellow SK, Adams MA, Bennett BM, Siemens DR, Graham CH. Frederiksen LJ, et al. Among authors: graham ch. Clin Cancer Res. 2007 Apr 1;13(7):2199-206. doi: 10.1158/1078-0432.CCR-06-1807. Clin Cancer Res. 2007. PMID: 17404104

6

Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide.

Siemens DR, Hu N, Sheikhi AK, Chung E, Frederiksen LJ, Pross H, Graham CH. Siemens DR, et al. Among authors: graham ch. Cancer Res. 2008 Jun 15;68(12):4746-53. doi: 10.1158/0008-5472.CAN-08-0054. Cancer Res. 2008. PMID: 18559521

7

Phase II study of nitric oxide donor for men with increasing prostate-specific antigen level after surgery or radiotherapy for prostate cancer.

Siemens DR, Heaton JP, Adams MA, Kawakami J, Graham CH. Siemens DR, et al. Among authors: graham ch. Urology. 2009 Oct;74(4):878-83. doi: 10.1016/j.urology.2009.03.004. Epub 2009 May 24. Urology. 2009. PMID: 19476985 Clinical Trial.

8

Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide.

Barsoum IB, Hamilton TK, Li X, Cotechini T, Miles EA, Siemens DR, Graham CH. Barsoum IB, et al. Among authors: graham ch. Cancer Res. 2011 Dec 15;71(24):7433-41. doi: 10.1158/0008-5472.CAN-11-2104. Epub 2011 Oct 17. Cancer Res. 2011. PMID: 22006996

9

Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer.

Hamilton TK, Hu N, Kolomitro K, Bell EN, Maurice DH, Graham CH, Siemens DR. Hamilton TK, et al. Among authors: graham ch. World J Urol. 2013 Apr;31(2):325-30. doi: 10.1007/s00345-012-0848-7. Epub 2012 Mar 2. World J Urol. 2013. PMID: 22383129

10

Thromboelastography identifies hypercoagulablilty and predicts thromboembolic complications in patients with prostate cancer.

Toukh M, Siemens DR, Black A, Robb S, Leveridge M, Graham CH, Othman M. Toukh M, et al. Among authors: graham ch. Thromb Res. 2014 Jan;133(1):88-95. doi: 10.1016/j.thromres.2013.10.007. Epub 2013 Oct 12. Thromb Res. 2014. PMID: 24246296

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters